Marshall Wace North America’s Coherus Oncology CHRS Stock Holding History

Marshall Wace North America’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell
2021 Q1	$352K	Buy
2018 Q4	–	Sell
2018 Q3	$354K	Sell
2018 Q2	$8.96M	Buy
2018 Q1	$168K	Buy
2017 Q4	$101K	Buy
2017 Q2	–	Sell
2017 Q1	$1.33M	Buy